ARCHIVES

Phase II Trial of BIND-014 Shows Anti-Tumor Activity in Q3W Arm

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

New Agent Targets Glioma Tumor Cells Prior To Surgery

May 30, 2003

Matrisian, Nelson, to lead review of NCI translational research programs.

September 23, 2005

Crout, Finkel Replaced at FDA; Hayes Combine Biologics, Drugs

April 2, 1982

Seven Organizations To Use NCI-Army Coding System.

September 1, 2000

Study: Blood Test More Accurate Than Traditional Tumor Biopsy

April 26, 2013

In Brief: Senate Confirms Sullivan, Who Fires 100 HHS Political Appointees: Wyngaarden Still On Job

March 10, 1989